APA

Sauter P., Chehadeh W., Lobert P., Lazrek M., Goffard A., Soumillon M., Caloone D., Vantyghem M., Weill J., Fajardy I., Alm G., Lucas B. & Hober D. (20080513). A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. : Journal of medical virology.

Chicago

Sauter Pierre, Chehadeh Wassim, Lobert Pierre-Emmanuel, Lazrek Mouna, Goffard Anne, Soumillon Magalie, Caloone Delphine, Vantyghem Marie-Christine, Weill Jacques, Fajardy Isabelle, Alm Gunnar, Lucas Bernadette and Hober Didier. 20080513. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. : Journal of medical virology.

Harvard

Sauter P., Chehadeh W., Lobert P., Lazrek M., Goffard A., Soumillon M., Caloone D., Vantyghem M., Weill J., Fajardy I., Alm G., Lucas B. and Hober D. (20080513). A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. : Journal of medical virology.

MLA

Sauter Pierre, Chehadeh Wassim, Lobert Pierre-Emmanuel, Lazrek Mouna, Goffard Anne, Soumillon Magalie, Caloone Delphine, Vantyghem Marie-Christine, Weill Jacques, Fajardy Isabelle, Alm Gunnar, Lucas Bernadette and Hober Didier. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. : Journal of medical virology. 20080513.